13 Best Russell 2000 Stocks to Buy Right Now

Page 11 of 12

​2. BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Number of Hedge Fund Holders: 61

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the Best Russell 2000 Stocks to Buy Right Now. On January 20, Tiago Fauth from Wells Fargo reiterated a Buy rating on the stock and raised the price target to $88 from $84. Earlier on January 12, TD Cowen also reiterated a Buy rating on the stock with a $95 price target.

​Fauth from Wells Fargo noted that Attruby posted a strong revenue beat in Q4. As a result, Wells Fargo raised 2026 estimates by 10%. The firm noted that it expects some seasonal volatility in Q1 2026, but expects strong quarter-over-quarter growth during the rest of the year.

​Similarly, TD Cowen also highlighted that Attruby generated a revenue of roughly $146 million in the fourth quarter. The firm highlighted that this exceeded the expectations by 9%. Importantly, the quarter marked the completion of the first year for the drug, where it generated more than $362 million. The firm remains optimistic about the first-quarter data, as the company will reveal the outcome of BridgeBio Pharma, Inc.’s (NASDAQ:BBIO) Infi program. TD Cowen expects the data to support a best-in-class profile.

​BridgeBio Pharma, Inc. (NASDAQ:BBIO) develops therapies for genetic diseases and cancers, supporting its oncology-focused spin-off, BridgeBio Oncology Therapeutics (BBOT), which advances precision cancer treatments targeting key oncogenes, such as RAS and PI3K, into clinical trials.

Page 11 of 12